Top in hem/onc: Decline in cancer mortality; dispelling myths about asset protection
Click Here to Manage Email Alerts
Since 1991, the rate of cancer mortality has declined by 33% in the United States, which translates to an estimated 3.8 million fewer cancer deaths over the past 30 years, according to a report from the American Cancer Society.
The recent decline in cancer mortality can largely be attributed to “reductions in smoking, but also because of early detection for some cancers and better treatment,” Rebecca Siegel, MPH, senior scientific director of surveillance research at the American Cancer Society, told Healio. It was the top story in hematology/oncology last week.
Another top story dispelled some of the misconceptions that physicians may have when protecting their assets from potential lawsuits. The article includes insurance, legal and financial advice from David B. Mandell, JD, MBA, attorney and founder of the wealth management firm OJM Group.
Read these and more top stories in hematology/oncology below:
Cancer mortality declines 33% in past 30 years; prostate cancer cases on the rise
Cancer mortality in the United States has declined by 33% since 1991, according to an American Cancer Society report. Read more.
Common myths, misconceptions about asset protection may hold back your planning
As advisors to physicians throughout the U. S., we often learn what misconceptions physicians have regarding how to protect their assets from potential lawsuits. In this article, I hope to dispel some incorrect assumptions you may have. Read more.
Researcher develops cancer drug in memory of girl who died of neuroblastoma
Linda H. Malkas, PhD, remembers the day a photograph for a newspaper changed her life. Read more.
BLOG: Prior authorizations deny patients necessary medical care
Our health care system is broken on multiple levels. As a medical community, we somehow seem to be hastening its untimely demise by continuing to partake in systems that waste inordinate amounts of time and result in the delivery of suboptimal patient care, such as the burdensome, inefficient, time-consuming and overall unnecessary prior authorization system. Read more.
Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment
It’s not often that a 2 a.m. phone call marks the highlight of someone’s career. Read more.